Imagine trying to decide if a patient should keep taking blood thinners when they are very sick and near the end of their life. Often, these drugs cause dangerous bleeding without actually helping the patient feel better. This project creates a digital tool to help doctors and families make the right choice together, tailored to the person's specific background and health needs.
Cancer patients at the end of life often continue taking blood thinners that cause dangerous bleeding and increase healthcare costs without improving their quality of life.
A web-based shared decision support tool (SDST) that helps doctors and patients decide on the appropriate use of antithrombotic therapy.
If you are a software developer dealing with a lack of specialized palliative care tools — this project developed a web-based shared decision support tool (SDST) that helps clinicians and patients decide when to stop antithrombotic therapy. This provides a validated clinical logic for a new market segment in end-of-life care.
If you are a hospital network dealing with high costs and complications from unnecessary medication at the end of life — this project developed a decision process that prevents bleeding complications. This leads to considerable cost savings and higher treatment satisfaction for patients and carers.
If you are an insurer dealing with the high cost of treating avoidable hemorrhage in palliative cancer patients — this project developed a tool to ensure appropriate use of antithrombotic therapy. This reduces the disease burden and lowers healthcare costs across EU regions.
Based on available project data, no specific pricing or cost for the tool is mentioned; however, the project aims to generate considerable cost savings for healthcare systems.
Yes, the project includes a targeted implementation and exploitation plan to enable use across Europe and incorporation into national and pan-European clinical guidelines.
Based on available project data, specific IP or licensing terms are not provided, but the project focuses on a web-based application for clinical use.
The tool is designed as a user-friendly, web-based shared decision support tool (SDST) to be used by healthcare professionals, patients, and carers during the decision-making process.
The project period runs from 2022-10-01 to 2027-09-30, with a Randomised Clinical Trial planned to test and optimize the tool.
The consortium is heavily weighted toward academic and research institutions, with 7 universities and 3 research centers. Business integration is low, with only 1 industry partner and 1 SME, representing a 7% industry ratio. This suggests the project is currently in a high-evidence generation phase rather than a commercial rollout phase.
Contact Academisch Ziekenhuis Leiden for details on the SDST implementation plan.
Contact us to find licensing opportunities for the SERENITY decision support tool.
